{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:36:48Z","timestamp":1791344208201,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T00:00:00Z","timestamp":1120694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1038\/sj.leu.2403859","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T11:41:49Z","timestamp":1120736509000},"page":"1543-1549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia"],"prefix":"10.1038","volume":"19","author":[{"given":"M R","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Chism","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Milella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Estey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kaldjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sebolt-Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Konopleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Andreeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,7]]},"reference":[{"key":"BF2403859_CR1","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/sj.leu.2401715","volume":"14","author":"NJ Ketley","year":"2000","unstructured":"Ketley NJ, Allen PD, Kelsey SM, Newland AC . Mechanisms of resistance to apoptosis in human AML blasts: the role of differentiation-induced perturbations of cell-cycle checkpoints. Leukemia 2000; 14: 620\u2013628.","journal-title":"Leukemia"},{"key":"BF2403859_CR2","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1182\/blood-2002-06-1714","volume":"101","author":"G Del Poeta","year":"2003","unstructured":"Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A et al. Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003; 101: 2125\u20132131.","journal-title":"Blood"},{"key":"BF2403859_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL et al. Signal transduction mediated by the Ras\/Raf\/MEK\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 2003; 17: 1263\u20131293.","journal-title":"Leukemia"},{"key":"BF2403859_CR4","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","volume":"101","author":"LC Platanias","year":"2003","unstructured":"Platanias LC . Map kinase signaling pathways and hematologic malignancies. Blood 2003; 101: 4667\u20134679.","journal-title":"Blood"},{"key":"BF2403859_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1172\/JCI12807","volume":"108","author":"M Milella","year":"2001","unstructured":"Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D et al. Therapeutic targeting of the MEK\/MAPK signal transduction module in acute myeloid leukemia. J Clin Invest 2001; 108: 851\u2013859.","journal-title":"J Clin Invest"},{"key":"BF2403859_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrd1066","volume":"2","author":"J Dancey","year":"2003","unstructured":"Dancey J, Sausville EA . Issues and progress with protein kinase inhibitors for cancer treatment. Nat Rev Drug Discov 2003; 2: 296\u2013313.","journal-title":"Nat Rev Drug Discov"},{"key":"BF2403859_CR7","doi-asserted-by":"publisher","first-page":"6594","DOI":"10.1038\/sj.onc.1204083","volume":"19","author":"JS Sebolt-Leopold","year":"2000","unstructured":"Sebolt-Leopold JS . Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 2000; 19: 6594\u20136599.","journal-title":"Oncogene"},{"key":"BF2403859_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.seminoncol.2003.08.012","volume":"30","author":"LF Allen","year":"2003","unstructured":"Allen LF, Sebolt-Leopold J, Meyer MB . CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol 2003; 30: 105\u2013116.","journal-title":"Semin Oncol"},{"key":"BF2403859_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/cyto.1067","volume":"46","author":"S Chow","year":"2001","unstructured":"Chow S, Patel H, Hedley DW . Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 2001; 46: 72\u201378.","journal-title":"Cytometry"},{"key":"BF2403859_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cyto.a.10072","volume":"55A","author":"PO Krutzik","year":"2003","unstructured":"Krutzik PO, Nolan GP . Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry 2003; 55A: 61\u201370.","journal-title":"Cytometry"},{"key":"BF2403859_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt0202-155","volume":"20","author":"OD Perez","year":"2002","unstructured":"Perez OD, Nolan GP . Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 2002; 20: 155\u2013162.","journal-title":"Nat Biotechnol"},{"key":"BF2403859_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/jcb.10262","volume":"86","author":"PL Tazzari","year":"2002","unstructured":"Tazzari PL, Cappellini A, Bortul R, Ricci F, Billi AM, Tabellini G et al. Flow cytometric detection of total and serine 473 phosphorylated Akt. J Cell Biochem 2002; 86: 704\u2013715.","journal-title":"J Cell Biochem"},{"key":"BF2403859_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1006\/clim.1998.4654","volume":"90","author":"TA Fleisher","year":"1999","unstructured":"Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM . Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol 1999; 90: 425\u2013430.","journal-title":"Clin Immunol"},{"key":"BF2403859_CR14","doi-asserted-by":"publisher","first-page":"10805","DOI":"10.1073\/pnas.191567898","volume":"98","author":"T Zell","year":"2001","unstructured":"Zell T, Khoruts A, Ingulli E, Bonnevier JL, Mueller DL, Jenkins MK . Single-cell analysis of signal transduction in CD4T cells stimulated by antigen in vivo. Proc Natl Acad Sci USA 2001; 98: 10805\u201310810.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403859_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0301-472X(00)00529-4","volume":"28","author":"KU Birkenkamp","year":"2000","unstructured":"Birkenkamp KU, Esselink MT, Kruijer W, Vellenga E . An inhibitor of PI3-K differentially affects proliferation and IL-6 protein secretion in normal and leukemic myeloid cells depending on the stage of differentiation. Exp Hematol 2000; 28: 1239\u20131249.","journal-title":"Exp Hematol"},{"key":"BF2403859_CR16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1182\/blood.V94.5.1601","volume":"94","author":"S Fichelson","year":"1999","unstructured":"Fichelson S, Freyssinier JM, Picard F, Fontenay-Roupie M, Guesnu M, Cherai M et al. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors. Blood 1999; 94: 1601\u20131613.","journal-title":"Blood"},{"key":"BF2403859_CR17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood.V89.4.1189","volume":"89","author":"RM Lemoli","year":"1997","unstructured":"Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L et al. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89: 1189\u20131196.","journal-title":"Blood"},{"key":"BF2403859_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0301-472X(00)00506-3","volume":"28","author":"CM Verfaillie","year":"2000","unstructured":"Verfaillie CM, Almeida-Porada G, Wissink S, Zanjani ED . Kinetics of engraftment of CD34(\u2212) and CD34(+) cells from mobilized blood differs from that of CD34(\u2212) and CD34(+) cells from bone marrow. Exp Hematol 2000; 28: 1071\u20131079.","journal-title":"Exp Hematol"},{"key":"BF2403859_CR19","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1182\/blood.V99.6.2037","volume":"99","author":"U Steidl","year":"2002","unstructured":"Steidl U, Kronenwett R, Rohr UP, Fenk R, Kliszewski S, Maercker C et al. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood 2002; 99: 2037\u20132044.","journal-title":"Blood"},{"key":"BF2403859_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1046\/j.1365-2141.2003.04673.x","volume":"123","author":"RM Lemoli","year":"2003","unstructured":"Lemoli RM, Bertolini F, Petrucci MT, Gregorj C, Ricciardi MR, Fogli M et al. Functional and kinetic characterization of granulocyte colony-stimulating factor-primed CD34\u2212 human stem cells. Br J Haematol 2003; 123: 720\u2013729.","journal-title":"Br J Haematol"},{"key":"BF2403859_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/sj.leu.2400617","volume":"11","author":"M Towatari","year":"1997","unstructured":"Towatari M, Iida H, Tanimoto M, Iwata H, Hamaguchi M, Saito H . Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 1997; 11: 479\u2013484.","journal-title":"Leukemia"},{"key":"BF2403859_CR22","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.leu.2403032","volume":"17","author":"P Lunghi","year":"2003","unstructured":"Lunghi P, Tabilio A, Dall'Aglio PP, Ridolo E, Carlo-Stella C, Pelicci PG et al. Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts. Leukemia 2003; 17: 1783\u20131793.","journal-title":"Leukemia"},{"key":"BF2403859_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1073\/pnas.95.3.1091","volume":"95","author":"M Cheng","year":"1998","unstructured":"Cheng M, Sexl V, Sherr CJ, Roussel MF . Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998; 95: 1091\u20131096.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403859_CR24","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1074\/jbc.M006132200","volume":"276","author":"R Hoshino","year":"2001","unstructured":"Hoshino R, Tanimura S, Watanabe K, Kataoka T, Kohno M . Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: upregulation of p27(Kip1). J Biol Chem 2001; 276: 2686\u20132692.","journal-title":"J Biol Chem"},{"key":"BF2403859_CR25","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/sj.onc.1202647","volume":"18","author":"K Balmanno","year":"1999","unstructured":"Balmanno K, Cook SJ . Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 1999; 18: 3085\u20133097.","journal-title":"Oncogene"},{"key":"BF2403859_CR26","first-page":"99","volume":"11","author":"EK Lobenhofer","year":"2000","unstructured":"Lobenhofer EK, Huper G, Iglehart JD, Marks JR . Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ 2000; 11: 99\u2013110.","journal-title":"Cell Growth Differ"},{"key":"BF2403859_CR27","doi-asserted-by":"publisher","first-page":"26563","DOI":"10.1074\/jbc.274.37.26563","volume":"274","author":"S Kamakura","year":"1999","unstructured":"Kamakura S, Moriguchi T, Nishida E . Activation of the protein kinase ERK5\/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999; 274: 26563\u201326571.","journal-title":"J Biol Chem"},{"key":"BF2403859_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0014-5793(01)02651-5","volume":"502","author":"N Mody","year":"2001","unstructured":"Mody N, Leitch J, Armstrong C, Dixon J, Cohen P . Effects of MAP kinase cascade inhibitors on the MKK5\/ERK5 pathway. FEBS Lett 2001; 502: 21\u201324.","journal-title":"FEBS Lett"},{"key":"BF2403859_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1042\/bj20020372","volume":"366","author":"MS Squires","year":"2002","unstructured":"Squires MS, Nixon PM, Cook SJ . Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1\/2 but not ERK5\/BMK1. Biochem J 2002; 366: 673\u2013680.","journal-title":"Biochem J"},{"key":"BF2403859_CR30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","volume":"102","author":"Q Xu","year":"2003","unstructured":"Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M . Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood 2003; 102: 972\u2013980.","journal-title":"Blood"},{"key":"BF2403859_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.leu.2403220","volume":"18","author":"S Zhao","year":"2004","unstructured":"Zhao S, Konopleva M, Cabreira-Hansen M, Xie Z, Hu W, Milella M et al. Inhibition of phosphatidylinositol 3-kinase (PI3K) dephosphorylates BAD and promotes apoptosis in myeloid leukemias. Leukemia 2004; 18: 267\u2013275.","journal-title":"Leukemia"},{"key":"BF2403859_CR32","first-page":"4885","volume":"6","author":"FM Sirotnak","year":"2000","unstructured":"Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG . Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin Cancer Res 2000; 6: 4885\u20134892.","journal-title":"Clin Cancer Res"},{"key":"BF2403859_CR33","first-page":"2091","volume":"8","author":"JP MacKeigan","year":"2002","unstructured":"MacKeigan JP, Taxman DJ, Hunter D, Earp III HS, Graves LM, Ting JP . Inactivation of the antiapoptotic phosphatidylinositol 3-kinase\u2013Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition. Clin Cancer Res 2002; 8: 2091\u20132099.","journal-title":"Clin Cancer Res"},{"key":"BF2403859_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1470-2045(02)00883-5","volume":"3","author":"E Wilkinson","year":"2002","unstructured":"Wilkinson E . Surprise phase III failure for ZD1839. Lancet Oncol 2002; 3: 583.","journal-title":"Lancet Oncol"},{"key":"BF2403859_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/sj.leu.2402925","volume":"17","author":"WL Blalock","year":"2003","unstructured":"Blalock WL, Navolanic PM, Steelman LS, Shelton JG, Moye PW, Lee JT et al. Requirement for the PI3K\/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Leukemia 2003; 17: 1058\u20131067.","journal-title":"Leukemia"},{"key":"BF2403859_CR36","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/sj.onc.1206321","volume":"22","author":"JG Shelton","year":"2003","unstructured":"Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW et al. Effects of the RAF\/MEK\/ERK and PI3K\/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells. Oncogene 2003; 22: 2478\u20132492.","journal-title":"Oncogene"},{"key":"BF2403859_CR37","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1182\/blood.V99.9.3461","volume":"99","author":"M Milella","year":"2002","unstructured":"Milella M, Estrov Z, Kornblau SM, Carter BZ, Konopleva M, Tari A et al. Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK\/MAPK pathways in acute myelogenous leukemia. Blood 2002; 99: 3461\u20133464.","journal-title":"Blood"},{"key":"BF2403859_CR38","unstructured":"Milella M, Precupanu C, Gregorj C, Ricciardi M, Petrucci M, Kornblau SM et al. Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects. Curr Pharm Des, in press."}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403859.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403859","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403859.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:58:46Z","timestamp":1648778326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,7]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9,1]]}},"alternative-id":["BF2403859"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403859","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,7]]},"assertion":[{"value":"6 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}